Global Opioids Drug Market Research Report 2021

Global Opioids Drug Market Research Report 2021

Table of Contents
1 Opioids Drug Market Overview
1.1 Product Overview and Scope of Opioids Drug
1.2 Opioids Drug Segment by Type
1.2.1 Global Opioids Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Others
1.3 Opioids Drug Segment by Application
1.3.1 Opioids Drug Sales Comparison by Application: (2021-2027)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Global Opioids Drug Market Size Estimates and Forecasts
1.4.1 Global Opioids Drug Revenue 2016-2027
1.4.2 Global Opioids Drug Sales 2016-2027
1.4.3 Opioids Drug Market Size by Region: 2016 Versus 2021 Versus 2027
2 Opioids Drug Market Competition by Manufacturers
2.1 Global Opioids Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Opioids Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Opioids Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Opioids Drug Manufacturing Sites, Area Served, Product Type
2.5 Opioids Drug Market Competitive Situation and Trends
2.5.1 Opioids Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Opioids Drug Players Market Share by Revenue
2.5.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioids Drug Retrospective Market Scenario by Region
3.1 Global Opioids Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Opioids Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Opioids Drug Market Facts & Figures by Country
3.3.1 North America Opioids Drug Sales by Country
3.3.2 North America Opioids Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Opioids Drug Market Facts & Figures by Country
3.4.1 Europe Opioids Drug Sales by Country
3.4.2 Europe Opioids Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Opioids Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Opioids Drug Sales by Region
3.5.2 Asia Pacific Opioids Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Opioids Drug Market Facts & Figures by Country
3.6.1 Latin America Opioids Drug Sales by Country
3.6.2 Latin America Opioids Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Opioids Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Opioids Drug Sales by Country
3.7.2 Middle East and Africa Opioids Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Opioids Drug Historic Market Analysis by Type
4.1 Global Opioids Drug Sales Market Share by Type (2016-2021)
4.2 Global Opioids Drug Revenue Market Share by Type (2016-2021)
4.3 Global Opioids Drug Price by Type (2016-2021)
5 Global Opioids Drug Historic Market Analysis by Application
5.1 Global Opioids Drug Sales Market Share by Application (2016-2021)
5.2 Global Opioids Drug Revenue Market Share by Application (2016-2021)
5.3 Global Opioids Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Teva Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Corporation Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Purdue Pharma Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mallinckrodt Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Amneal Pharma
6.4.1 Amneal Pharma Corporation Information
6.4.2 Amneal Pharma Description and Business Overview
6.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Amneal Pharma Product Portfolio
6.4.5 Amneal Pharma Recent Developments/Updates
6.5 Collegium
6.5.1 Collegium Corporation Information
6.5.2 Collegium Description and Business Overview
6.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Collegium Product Portfolio
6.5.5 Collegium Recent Developments/Updates
6.6 J&J
6.6.1 J&J Corporation Information
6.6.2 J&J Description and Business Overview
6.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 J&J Product Portfolio
6.6.5 J&J Recent Developments/Updates
6.7 Endo
6.6.1 Endo Corporation Information
6.6.2 Endo Description and Business Overview
6.6.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Endo Product Portfolio
6.7.5 Endo Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pfizer Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 INSYS
6.9.1 INSYS Corporation Information
6.9.2 INSYS Description and Business Overview
6.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 INSYS Product Portfolio
6.9.5 INSYS Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Mylan Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Opioids Drug Description and Business Overview
6.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Hikma Product Portfolio
6.11.5 Hikma Recent Developments/Updates
6.12 Egalet
6.12.1 Egalet Corporation Information
6.12.2 Egalet Opioids Drug Description and Business Overview
6.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Egalet Product Portfolio
6.12.5 Egalet Recent Developments/Updates
7 Opioids Drug Manufacturing Cost Analysis
7.1 Opioids Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Opioids Drug
7.4 Opioids Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Opioids Drug Distributors List
8.3 Opioids Drug Customers
9 Opioids Drug Market Dynamics
9.1 Opioids Drug Industry Trends
9.2 Opioids Drug Growth Drivers
9.3 Opioids Drug Market Challenges
9.4 Opioids Drug Market Restraints
10 Global Market Forecast
10.1 Opioids Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Opioids Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Opioids Drug by Type (2022-2027)
10.2 Opioids Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Opioids Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Opioids Drug by Application (2022-2027)
10.3 Opioids Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Opioids Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Opioids Drug by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Opioids Drug Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Opioids Drug Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Opioids Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Opioids Drug Covered in This Study
Table 5. Global Opioids Drug Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Opioids Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Opioids Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Opioids Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Opioids Drug Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Opioids Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Opioids Drug Product Type
Table 12. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Opioids Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Opioids Drug Sales by Region (2016-2021) & (M Units)
Table 16. Global Opioids Drug Sales Market Share by Region (2016-2021)
Table 17. Global Opioids Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 19. North America Opioids Drug Sales Market Share by Country (2016-2021)
Table 20. North America Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Opioids Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 23. Europe Opioids Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Opioids Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Opioids Drug Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Opioids Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Opioids Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Opioids Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Opioids Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Opioids Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Opioids Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Opioids Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Opioids Drug Sales (M Units) by Type (2016-2021)
Table 39. Global Opioids Drug Sales Market Share by Type (2016-2021)
Table 40. Global Opioids Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Opioids Drug Revenue Share by Type (2016-2021)
Table 42. Global Opioids Drug Price (USD/Unit) by Type (2016-2021)
Table 43. Global Opioids Drug Sales (M Units) by Application (2016-2021)
Table 44. Global Opioids Drug Sales Market Share by Application (2016-2021)
Table 45. Global Opioids Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Opioids Drug Revenue Share by Application (2016-2021)
Table 47. Global Opioids Drug Price (USD/Unit) by Application (2016-2021)
Table 48. Teva Corporation Information
Table 49. Teva Description and Business Overview
Table 50. Teva Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Teva Opioids Drug Product
Table 52. Teva Recent Developments/Updates
Table 53. Purdue Pharma Corporation Information
Table 54. Purdue Pharma Description and Business Overview
Table 55. Purdue Pharma Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Purdue Pharma Opioids Drug Product
Table 57. Purdue Pharma Recent Developments/Updates
Table 58. Mallinckrodt Corporation Information
Table 59. Mallinckrodt Description and Business Overview
Table 60. Mallinckrodt Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Mallinckrodt Opioids Drug Product
Table 62. Mallinckrodt Recent Developments/Updates
Table 63. Amneal Pharma Corporation Information
Table 64. Amneal Pharma Description and Business Overview
Table 65. Amneal Pharma Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Amneal Pharma Opioids Drug Product
Table 67. Amneal Pharma Recent Developments/Updates
Table 68. Collegium Corporation Information
Table 69. Collegium Description and Business Overview
Table 70. Collegium Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Collegium Opioids Drug Product
Table 72. Collegium Recent Developments/Updates
Table 73. J&J Corporation Information
Table 74. J&J Description and Business Overview
Table 75. J&J Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. J&J Opioids Drug Product
Table 77. J&J Recent Developments/Updates
Table 78. Endo Corporation Information
Table 79. Endo Description and Business Overview
Table 80. Endo Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Endo Opioids Drug Product
Table 82. Endo Recent Developments/Updates
Table 83. Pfizer Corporation Information
Table 84. Pfizer Description and Business Overview
Table 85. Pfizer Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Pfizer Opioids Drug Product
Table 87. Pfizer Recent Developments/Updates
Table 88. INSYS Corporation Information
Table 89. INSYS Description and Business Overview
Table 90. INSYS Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. INSYS Opioids Drug Product
Table 92. INSYS Recent Developments/Updates
Table 93. Mylan Corporation Information
Table 94. Mylan Description and Business Overview
Table 95. Mylan Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Mylan Opioids Drug Product
Table 97. Mylan Recent Developments/Updates
Table 98. Hikma Corporation Information
Table 99. Hikma Description and Business Overview
Table 100. Hikma Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Hikma Opioids Drug Product
Table 102. Hikma Recent Developments/Updates
Table 103. Egalet Corporation Information
Table 104. Egalet Description and Business Overview
Table 105. Egalet Opioids Drug Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Egalet Opioids Drug Product
Table 107. Egalet Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Opioids Drug Distributors List
Table 111. Opioids Drug Customers List
Table 112. Opioids Drug Market Trends
Table 113. Opioids Drug Growth Drivers
Table 114. Opioids Drug Market Restraints
Table 115. Global Opioids Drug Sales Forecast by Type (2022-2027) & (M Units)
Table 116. Global Opioids Drug Sales Market Share Forecast by Type (2022-2027)
Table 117. Global Opioids Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global Opioids Drug Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global Opioids Drug Sales Forecast by Application (2022-2027) & (M Units)
Table 120. Global Opioids Drug Sales Market Share Forecast by Application (2022-2027)
Table 121. Global Opioids Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global Opioids Drug Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global Opioids Drug Sales Forecast by Region (2022-2027) & (M Units)
Table 124. Global Opioids Drug Sales Market Share Forecast by Region (2022-2027)
Table 125. Global Opioids Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global Opioids Drug Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioids Drug
Figure 2. Global Opioids Drug Market Share by Type in 2020 & 2027
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Others Product Picture
Figure 8. Global Opioids Drug Market Share by Application in 2020 & 2027
Figure 9. Pain Relief
Figure 10. Anesthesia
Figure 11. Others
Figure 12. Global Opioids Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Opioids Drug Market Size 2016-2027 (US$ Million)
Figure 14. Global Opioids Drug Sales 2016-2027 (M Units)
Figure 15. Global Opioids Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Opioids Drug Sales Share by Manufacturers in 2020
Figure 17. Global Opioids Drug Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Opioids Drug Players: Market Share by Revenue in 2020
Figure 19. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Opioids Drug Sales Market Share by Region (2016-2021)
Figure 21. Global Opioids Drug Sales Market Share by Region in 2020
Figure 22. Global Opioids Drug Revenue Market Share by Region (2016-2021)
Figure 23. Global Opioids Drug Revenue Market Share by Region in 2020
Figure 24. U.S. Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Opioids Drug by Type (2016-2021)
Figure 49. Sales Market Share of Opioids Drug by Application (2016-2021)
Figure 50. Sales Market Share of Opioids Drug by Application in 2020
Figure 51. Revenue Share of Opioids Drug by Application (2016-2021)
Figure 52. Revenue Share of Opioids Drug by Application in 2020
Figure 53. Manufacturing Cost Structure of Opioids Drug
Figure 54. Manufacturing Process Analysis of Opioids Drug
Figure 55. Opioids Drug Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs